link to the trial on clinicaltrials.gov is here: https://clinicaltrials.gov/ct2/show/NCT04261517
patients in both tx and control arm fared better than in the french study from earlier this week, suggesting patients were healthier / lower risk at baseline
patients got slightly lower dose in this study (400 mg / day) vs the french study (600 mg / day)